In another study, CD patients with the IBD risk allele ATG16L1-T300A in the ATG16L1 gene (important in innate immunity and inflammation) was associated with impaired clearance of patho-symbionts in ileal inflammation [66]. This evidence concerns the gene ATG16L1 and irritable bowel syndrome.